215 related articles for article (PubMed ID: 29295895)
21. A novel technique to quantify the kinetics of blood clot contraction based on the expulsion of fluorescently labeled albumin into serum.
Peshkova AD; Weisel JW; Litvinov RI
J Thromb Haemost; 2024 Jun; 22(6):1742-1748. PubMed ID: 38401713
[TBL] [Abstract][Full Text] [Related]
22. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
23. Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.
Dill V; Kirmes K; Han J; Klug M; Rosenbaum M; Viggiani G; von Scheidt M; List M; Herhaus P; Ruland J; Bassermann F; Laugwitz KL; Götze KS; Jost PJ; Jilg S; Bloxham CJ; Raake PWJ; Bernlochner I; Bongiovanni D
Platelets; 2024 Dec; 35(1):2358244. PubMed ID: 38845541
[TBL] [Abstract][Full Text] [Related]
24. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.
Tutwiler V; Litvinov RI; Lozhkin AP; Peshkova AD; Lebedeva T; Ataullakhanov FI; Spiller KL; Cines DB; Weisel JW
Blood; 2016 Jan; 127(1):149-59. PubMed ID: 26603837
[TBL] [Abstract][Full Text] [Related]
25. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
[TBL] [Abstract][Full Text] [Related]
26. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
27. [Decreased retraction of blood clots in patients with venous thromboembolic complications].
Bredikhin RA; Peshkova AD; Maliasev DV; Batrakova MV; Le Min J; Panasiuk MV; Fatkhullina LS; Ignat'ev IM; Khaĭrullin RN; Litvinov RI
Angiol Sosud Khir; 2018; 24(1):21-28. PubMed ID: 29688191
[TBL] [Abstract][Full Text] [Related]
28. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
29. Reduced clot retraction rate and altered platelet energy production in patients with asthma.
Tomasiak-Lozowska MM; Rusak T; Misztal T; Bodzenta-Lukaszyk A; Tomasiak M
J Asthma; 2016 Aug; 53(6):589-98. PubMed ID: 27145190
[TBL] [Abstract][Full Text] [Related]
30. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
[TBL] [Abstract][Full Text] [Related]
31. Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Nielsen CT; Heegaard NH; Linge P; Jönsen A; Hesselstrand R; Kahn R; Bengtsson AA
Rheumatology (Oxford); 2017 Mar; 56(3):408-416. PubMed ID: 28031442
[TBL] [Abstract][Full Text] [Related]
32. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus.
Cheng HH; Ho CM; Huang CJ; Hsu SS; Jiann BP; Chen JS; Huang JK; Chang HT; Lo YK; Yeh JH; Jan CR
Pharmacology; 2005 Mar; 73(4):169-74. PubMed ID: 15591819
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state.
Kiraz S; Ertenli I; Benekli M; Haznedaroğlu IC; Calgüneri M; Celik I; Apraş S; Kirazli S
Lupus; 1999; 8(9):737-41. PubMed ID: 10602446
[TBL] [Abstract][Full Text] [Related]
34. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
35. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.
Baroni Pietto MC; Glembotsky AC; Lev PR; Marín Oyarzún CR; De Luca G; Gomez G; Collado MV; Charó N; Cellucci AS; Heller PG; Goette NP; Marta RF
Immunobiology; 2024 Jan; 229(1):152782. PubMed ID: 38159527
[TBL] [Abstract][Full Text] [Related]
37. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the thrombin generation profile in systemic lupus erythematosus.
Kern A; Barabás E; Balog A; Burcsár S; Kiszelák M; Vásárhelyi B
Physiol Int; 2017 Mar; 104(1):35-41. PubMed ID: 28361572
[TBL] [Abstract][Full Text] [Related]
39. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
40. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]